Writing your favorite psychedelics newsletter. 🫠
[5-min read] Q&A with Joshua White, Founder & Advocate
[5-min read] Oregon Psilocybin Services releases new proposed rules.
[5-min read] Q&A with Ashley Carmen, Psychotherapist & Founder
[5-min read] Study suggests ketamine slows or reverses biological aging.
[5-min read] Q&A with Olivia MacDonell, Integration Specialist
[5-min read] Psilocybin beats escitalopram in well-being beyond depression.
[6-min read] Q&A with Rick Doblin, Activist & Founder
[5-min read] Study estimates 5 million Americans would benefit from psilocybin.
[5-min read] Q&A with April Pride, Creative Entrepreneur
[5-min read] AI-powered psychedelic company is approved to launch human trials.
